HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Shusaku Nakashima Selected Research
Shusaku Nakashima Research Topics
Disease
4
Rheumatoid Arthritis
12/2021 - 09/2014
3
Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2022 - 09/2020
3
Premature Birth (Birth, Premature)
01/2022 - 05/2019
2
Fever (Fevers)
01/2021 - 12/2020
1
Rheumatic Diseases (Rheumatism)
07/2022
1
COVID-19
07/2022
1
Oral Ulcer (Mouth Ulcer)
01/2022
1
Interstitial Lung Diseases (Interstitial Lung Disease)
09/2021
1
Juvenile Arthritis (Juvenile Idiopathic Arthritis)
09/2021
1
Disease Progression
01/2021
1
Multi-centric Castleman's Disease
01/2021
1
Ascites
01/2021
1
Edema (Dropsy)
01/2021
1
Fibrosis (Cirrhosis)
01/2021
1
Otitis Media
01/2021
1
Thrombocytopenia (Thrombopenia)
01/2021
1
Churg-Strauss Syndrome (Allergic Angiitis)
01/2021
1
Renal Insufficiency (Renal Failure)
01/2021
1
Nontuberculous Mycobacterium Infections
12/2020
1
Nephritis
12/2020
1
Communicable Diseases (Infectious Diseases)
12/2020
1
Inflammation (Inflammations)
12/2020
1
Infections
12/2020
1
Glomerulonephritis
12/2020
1
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
12/2020
1
Vasculitis (Vasculitides)
12/2020
1
Endarteritis
12/2020
1
Arthritis (Polyarthritis)
09/2020
1
Dermatomyositis (Dermatopolymyositis)
08/2020
1
Muscular Diseases (Myopathy)
08/2020
1
Rupture
05/2019
1
Lymphoproliferative Disorders (Lymphoproliferative Disorder)
03/2015
1
Lymphoma (Lymphomas)
03/2015
1
Respiratory Insufficiency (Respiratory Failure)
01/2015
Drug/Important Bio-Agent (IBA)
3
Interleukin-6 (Interleukin 6)
IBA
01/2022 - 01/2021
3
Cytokines
IBA
01/2022 - 01/2021
3
Adrenal Cortex Hormones (Corticosteroids)
IBA
01/2021 - 01/2015
2
Proteins (Proteins, Gene)
FDA Link
07/2022 - 01/2021
2
Immunoglobulin G (IgG)
IBA
07/2022 - 12/2020
2
Hydroxychloroquine (Plaquenil)
FDA Link
Generic
01/2022 - 09/2020
2
Immunosuppressive Agents (Immunosuppressants)
IBA
01/2022 - 01/2021
2
tocilizumab (atlizumab)
FDA Link
09/2021 - 01/2021
2
Pharmaceutical Preparations
IBA
03/2015 - 09/2014
2
Methotrexate (Mexate)
FDA Link
Generic
03/2015 - 09/2014
1
Immunoglobulin M (IgM)
IBA
07/2022
1
RNA (Ribonucleic Acid)
IBA
07/2022
1
COVID-19 Vaccines
IBA
07/2022
1
mRNA Vaccines
IBA
07/2022
1
BNT162 Vaccine
IBA
07/2022
1
SARS-CoV-2 spike protein
IBA
07/2022
1
Messenger RNA (mRNA)
IBA
07/2022
1
Glucocorticoids
IBA
01/2022
1
apremilast
IBA
01/2022
1
Interleukin-10 (Interleukin 10)
IBA
01/2022
1
Abatacept (Orencia)
FDA Link
12/2021
1
mepolizumab
IBA
01/2021
1
Rituximab (Mabthera)
FDA Link
01/2021
1
Interleukins
IBA
01/2021
1
Reticulin (Reticular Fiber)
IBA
01/2021
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2021
1
Antibodies
IBA
12/2020
1
Antineutrophil Cytoplasmic Antibodies (ANCA)
IBA
12/2020
1
antiglomerular basement membrane antibody
IBA
12/2020
1
Prednisolone (Predate)
FDA Link
Generic
10/2020
1
Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
FDA Link
08/2020
1
Enzymes
IBA
08/2020
1
Biological Products
IBA
05/2019
1
Antirheumatic Agents (DMARD)
IBA
05/2019
Therapy/Procedure
4
Therapeutics
01/2022 - 01/2015